Gsk Q3 2024 Earnings Call. Gsk ) is scheduled to announce q1 earnings results on. Strong performance from our future growth drivers, combined with a focus on cost, has offset the ongoing pandemic impact.
Gsk plc beats earnings expectations. Eps of $1.22 beats by $0.08 | revenue of $9.90b (10.93% y/y) beats by $435.91m.
Gsk Now Expects Annual Adjusted Earnings Per Share To Rise Between 17% And 20%, Excluding The Effect Of Currency Swings, Up From 14% To 17% Growth.
In the last reported quarter, the company delivered an earnings.
With Growing Earnings, There's A Likelihood That The.
30, 2024 11:39 am et gsk plc (gsk) stock by:
Eps Of $1.22 Beats By $0.08 | Revenue Of $9.90B (10.93% Y/Y) Beats By $435.91M.
Images References :
Gsk Began 2023 With A Quarterly Performance That Beat Analyst Expectations And Extended A Series Of Positive Results Thanks To Strong Sales Of Its Vaccines As Well As Hiv And Respiratory Medicines.
Gsk ) is scheduled to announce q1 earnings results on.
Eps Of $1.22 Beats By $0.08 | Revenue Of $9.90B (10.93% Y/Y) Beats By $435.91M.
Gsk) q3 2023 earnings conference call november 1,.